Both of you should listen to Amarin cc. I emphasize what impressed me. FDA has given discretion to physicians to administer Vascepa to statin-intolerant patients, i.e. patients who are not taking a statin as part of their med regimen but present risk/remain at risk for MACE etc. I stand to be corrected if I am not hearing correctly.
Market Data 
Markets 
AI
